Table 1 Qiagen Ingenuity Pathway Analysis identifies several pathways to be enriched, when comparing those hits detected in BH4 replete, verses deplete endothelial cells.
Canonical Pathways | −log (p-value) | Ratio |
---|---|---|
Protein Ubiquitination Pathway | 11.1 | 0.11 |
EIF2 Signaling | 11 | 0.118 |
Signaling by Rho Family GTPases | 9.91 | 0.105 |
RhoGDI Signaling | 7.7 | 0.11 |
Cardiac Hypertrophy Signaling | 3.93 | 0.0681 |
Chemokine Signaling | 3.66 | 0.113 |
Endothelin-1 Signaling | 3.39 | 0.0695 |
Mitochondrial Dysfunction | 3.21 | 0.0702 |
Hypoxia Signaling in the Cardiovascular System | 3.14 | 0.108 |
Tight Junction Signaling | 2.76 | 0.0659 |
TCA Cycle II (Eukaryotic) | 2.76 | 0.174 |
Wnt/β-catenin Signaling | 2.72 | 0.0651 |
Glutathione Redox Reactions II | 2.51 | 0.5 |
Proline Biosynthesis I | 2.51 | 0.5 |
NF-κB Signaling | 2.51 | 0.0611 |
Tetrahydrofolate Salvage from 5,10-methenyltetrahydrofolate | 2.3 | 0.4 |
NRF2-mediated Oxidative Stress Response | 2.28 | 0.057 |
VEGF Signaling | 2.01 | 0.068 |
eNOS Signaling | 2.01 | 0.0581 |
Oxidative Phosphorylation | 1.88 | 0.0642 |